BHVN:NYSE, Biohaven Ltd.

BHVN stock overview

Biohaven Ltd. (BHVN:NYSE) closed at $13.65 on November 19, 2026, up 5.81% on the day. The stock trades 25.2% below its 52-week high of $18.24 and 70.0% above its 52-week low of $8.03. Over the past year, it gained 41.7%. Biohaven Ltd. is part of the Health Care sector (Major Pharmaceuticals).

Key figures

Price
$13.65
Day change
+5.81%
Volume
3,261,960
Average volume
3,245,300
Market cap
2B+
52-week range
$8.03 – $18.24
50-day average
$13.41
200-day average
$12.35

Price action over the past year

In 252 trading sessions since November 19, 2025, BHVN closed higher on 113 days (45%). Its best day was October 22, 2026 (+25.02%) and its worst was September 10, 2026 (-14.73%). The stock moved 10% or more in a single session 14 times. It opened at least 5% above the previous day's high 4 times.

Recent signals

BHVN news

About Biohaven Ltd.

Biohaven Pharmaceutical Holding Co Ltd is a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological diseases, including rare disorders.

Similar stocks

Find more stocks like BHVN with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.